Protocol summary

Study aim
The purpose of this study is to investigate the effect of this syrup on reducing the intensity and duration of diarrhea in children hospitalized due to gastroenteritis.
Design
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 140 patients. A table of random numbers was used for randomization.
Settings and conduct
Study in Abuzar hospital of Ahvaz in 2 control and intervention groups are treated with the desired syrup and placebo and are examined by the questionnaire of the desired variables.
Participants/Inclusion and exclusion criteria
Inclusion criteria:Children from 12 months to 96 months, Suffering from acute gastroenteritis, Not receiving drug treatment before entering the study Exclusion criteria:Patients with severe dehydration, Presence of abnormal findings in stool test such as blood, Existence of surgical problem such as acute abdominal surgery, Suffering from another disease or receiving another drug during the study, Non-adherence to the treatment protocol or leaving the treatment before complete recovery, Frequent vomiting and drug intolerance, Patient withdrawal from participating in the study
Intervention groups
Giving corda mixa syrup compared to placebo
Main outcome variables
diarrhea, nausea, heartache, restlessness, fever, chills, sweating, headache, respiratory symptoms, the number of times of vomiting, the number of times of diarrhea per day, the number of days that the diarrhea lasted, and the volume and consistency of stool.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20200202046341N2
Registration date: 2024-04-21, 1403/02/02
Registration timing: retrospective

Last update: 2024-04-21, 1403/02/02
Update count: 0
Registration date
2024-04-21, 1403/02/02
Registrant information
Name
Neda Mohtasham
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 61 3551 2845
Email address
mohtasham-n@ajums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-02-20, 1402/12/01
Expected recruitment end date
2024-04-18, 1403/01/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Survey the Cordia myxa syrup effect in reducing the severity and duration of diarrhea in hospitalized children due to gastroenteritis
Public title
Effect of Cordia myxa syrup on acute diarrhea
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Children from 12 months to 96 months Suffering from acute gastroenteritis Not receiving drug treatment before entering the study
Exclusion criteria:
Patients with severe dehydration Presence of abnormal findings in stool test such as blood Existence of surgical problem such as acute abdominal surgery Suffering from another disease or receiving another drug during the study Non-adherence to the treatment protocol or leaving the treatment before complete recovery Frequent vomiting and drug intolerance Patient withdrawal from participating in the study
Age
From 12 months old to 96 months old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
Sample size
Target sample size: 140
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, we will use the permutation block randomization method. Blocking is usually used in order to balance the number of samples assigned to each of the studied groups. This feature helps the researchers so that the number of samples assigned to each of the studied groups is equal in cases where intermediate analyzes are needed during the sampling process. In this two-group clinical trial, block sizes of 4, 6, and 8 have been considered (in this method, the number of people assigned to each group in the blocks is equal). The randomization tool is also used from random sequence generation software (Random allocation software), which in addition to simple randomization, these random sequence generation software are capable of generating random sequence by block method. For concealment, we use Concealment Allocation, which refers to the method used to perform a random sequence on the participants in the study, so that the allocated group is not known before the allocation of the individual. By using opaque, sealed, numbered sequentially envelopes, in this method, each random sequence created is recorded on a card, and the cards are placed inside the envelopes in order. They are placed. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of registration of participants, based on the order of entry of qualified participants into the study, one of the envelopes will be opened and the assigned group of that participant will be revealed.
Blinding (investigator's opinion)
Double blinded
Blinding description
The participants who received the syrup and the health care personnel (nurses) who are responsible for taking care of the patients and provide the syrup to the patients without knowing whether the given syrup is a placebo or the syrup have participated in the research, but the main researcher, the officials Data collection and outcome assessors and, to a lesser extent, the Data Saftey and Monitoring Board and those preparing the draft article knew what syrup each person received.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Jundishapur Ahvaz University of Medical Sciences
Street address
Zeitoun Karmanani, Pasdaran Blvd., Nasrat St., Abu Dhar Hospital
City
Ahvaz
Province
Khouzestan
Postal code
616 361 4175
Approval date
2023-12-16, 1402/09/25
Ethics committee reference number
IR.AJUMS.REC.1402.477

Health conditions studied

1

Description of health condition studied
Gastroentritis
ICD-10 code
K52.8
ICD-10 code description
Other specified noninfective gastroenteritis and colitis

Primary outcomes

1

Description
Frequency of diarrhea
Timepoint
the first, second, third, seventh day and also at the end of the study (one week)
Method of measurement
Questionnaire made by the researcher

2

Description
Severity of diarrhea
Timepoint
the first, second, third, seventh day and also at the end of the study (one week)
Method of measurement
Questionnaire made by the researcher

3

Description
Stool consistancy
Timepoint
the first, second, third, seventh day and also at the end of the study (one week)
Method of measurement
Questionnaire made by the researcher

4

Description
Stool volume
Timepoint
the first, second, third, seventh day and also at the end of the study (one week)
Method of measurement
Questionnaire made by the researcher

5

Description
Percentage of recovered people
Timepoint
the first, second, third, seventh day and also at the end of the study (one week)
Method of measurement
Questionnaire made by the researcher

Secondary outcomes

empty

Intervention groups

1

Description
Control group: Placebo was administered three times a day (once every 8 hours).
Category
Placebo

2

Description
Intervention group: Cordia myxa syrup 3% in the amount of 3 mg per kilogram of body weight orally every 8 hours for 7 days
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Abuzar Hospital
Full name of responsible person
Mana Hafezi
Street address
Parastar st, Abuzar hospital
City
Ahvaz
Province
Khouzestan
Postal code
6163946593
Phone
+98 61 3444 0903
Email
fatemekhazaali80@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Ahmadi Moghadam
Street address
Esfand st, Jundishapur Ahvaz university
City
Ahvaz
Province
Khouzestan
Postal code
6135715794
Phone
+98 61 3311 4153
Email
fatemekhazaali80@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Ahvaz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Mana Hafezi
Position
Residant
Latest degree
Medical doctor
Other areas of specialty/work
Pediatrics
Street address
Parastar st.,Abuzar hospital
City
Ahvaz
Province
Khouzestan
Postal code
6163946593
Phone
+98 61 3444 0903
Email
fatemekhazaali80@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Mana Hafezi
Position
Residant
Latest degree
Medical doctor
Other areas of specialty/work
Pediatrics
Street address
Parastar st, Abuzar hospital
City
Ahvaz
Province
Khouzestan
Postal code
6163946593
Phone
+98 61 3444 0903
Email
fatemekhazaali80@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Ahvaz University of Medical Sciences
Full name of responsible person
Mana Hafezi
Position
Residant
Latest degree
Medical doctor
Other areas of specialty/work
Pediatrics
Street address
Nurse st, Abuzar hospital
City
Ahvaz
Province
Khouzestan
Postal code
6163946593
Phone
+98 61 3444 0903
Email
fatemekhazaali80@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
All data is potentially shareable after de-identifying individuals
When the data will become available and for how long
The access period starts after the results are printed
To whom data/document is available
The possibility of access for researchers working in academic and scientific institutions and people working in the industry
Under which criteria data/document could be used
For use and reference in other researches
From where data/document is obtainable
Mana Hafizi Birgani Children's specialist assistant +989166131934
What processes are involved for a request to access data/document
After confirming the access, they will get access within 24 to 48 hours
Comments
Loading...